Loar Holdings Inc. LOAR 深 沪
已收盘 05-22 16:00:00 美东时间
62.34
-0.210
-0.34%
华盛通- 最 高63.98
- 今 开62.65
- 成交量 46.32万股
- 最 低 61.64
- 昨 收 62.55
- 总市值 58.37亿
- 52周最高 91.19
- 市盈率 静 82.85
- 换手率 0.49%
- 52周最低 53.15
- 委 比 71.43%
- 总股本 9362.45万
- 历史最高 99.67
- 量 比 0.70
- 振 幅 3.74%
- 历史最低 42.57
- 每 手 1
- 风险率 8.20%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Loar Holdings Lowers FY2026 GAAP EPS Guidance from $0.60-$0.65 to $0.54-$0.59
Loar Holdings (NYSE:LOAR) lowers FY2026 GAAP EPS guidance from $0.60-$0.65 to $0.54-$0.59..
05-07 22:06
财报速睇 | Loar Holdings Inc. 2026财年Q1营收1.56亿美元，同比增长36.1%；归母净利润0.11亿美元，同比下滑27.3%
华盛资讯5月7日讯，Loar Holdings Inc.公布2026财年Q1业绩，公司Q1营收1.56亿美元，同比增长36.1%，归母净利润0.11亿美元，同比下滑27.3%。
05-07 21:18
财报速睇 | Loar Holdings Inc. 2026财年Q1营收1.56亿美元，同比增长36.1%；归母净利润0.11亿美元，同比下滑27.2%
华盛资讯5月7日讯，Loar Holdings Inc.公布2026财年Q1业绩，公司Q1营收1.56亿美元，同比增长36.1%，归母净利润0.11亿美元，同比下滑27.2%。
05-07 20:54
Loar Holdings Q1 Adj. EPS $0.34 Beats $0.16 Estimate, Sales $156.088M Beat $149.650M Estimate
Loar Holdings (NYSE:LOAR) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.16 by 112.5 percent. This is a 21.43 percent increase over earnings of $0.28 per share from the
05-07 20:31
Shares of aerospace and defense companies are trading higher amid market strength after reports suggesting that the U.S. and Iran are nearing an agreement to resolve the Middle East conflict, which would lessen energy costs and create room for new contracts
Shares of aerospace and defense companies are trading higher amid market streng...
05-07 02:40
Bears Pounce On Avis Budget, Lucid, MARA — Short Interest In These 10 Stocks Soars Above 40%
Choice Hotels, Avis Budget and Lucid stock all have short-interest above 50% of their free floats.
04-15 03:10
美股大行评级 | 摩根大通上调霸王茶姬至"超配"，目标价上调至16美元；康尼格拉食品遭高盛、瑞银等7家机构下调目标价
今日重点评级关注：Leerink Partners：维持Camp4 Therapeutics"跑赢大市"评级，目标价从8美元升至9美元；韦德布什：维持Arcus Biosciences"跑赢大市"评级，目标价从37美元升至41美元
04-06 16:27
Citigroup Maintains Buy on Loar Holdings, Lowers Price Target to $71
Citigroup analyst John Godyn maintains Loar Holdings (NYSE:LOAR) with a Buy and lowers the price target from $83 to $71.
04-03 00:21
